The Claim

In obese adults, a 5-week treatment with liraglutide at a dose of 3.0 mg does not change brain activation in response to food cues when the analysis does not account for weight loss, as assessed by functional magnetic resonance imaging (fMRI).

Source: Longer‐term liraglutide administration at the highest dose approved for obesity increases reward‐related orbitofrontal cortex activation in response to food cues: Implications for plateauing weight loss in response to anti‐obesity therapies

What the research says

Supports is higher

Support is ahead, but a single strong opposing study can change this.

Supports
66score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

How it works
1 study reviewed
In plain English

If someone is obese and takes a weight-loss drug called liraglutide for 5 weeks, their brain doesn’t react differently to pictures of food — at least not if we don’t factor in how much weight they lost.

See the scientific wording

In obese adults, 5 weeks of liraglutide 3.0 mg does not alter brain activation in response to food cues when analyzed without adjusting for weight loss, as measured by fMRI.

What the research says

1 study
  1. Study: Longer‐term liraglutide administration at the highest dose approved for obesity increases reward‐related orbitofrontal cortex activation in response to food cues: Implications for plateauing weight loss in response to anti‐obesity therapies

    The study found that when you don’t account for weight loss, liraglutide didn’t change how the brain responds to food pictures. That’s exactly what the claim says.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.